|
|
||||||||||
|
J Am Coll Cardiol, 2001; 37:9-18 © 2001 by the American College of Cardiology Foundation |

* Duke Clinical Research Institute, Durham, North Carolina, USA
Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA
Manuscript received December 8, 1999; revised manuscript received August 1, 2000, accepted September 20, 2000.
Reprint requests and correspondence: Dr. Matthew T. Roe, Duke Clinical Research Institute, P.O. Box 17969, Durham, North Carolina 27715
roe0001{at}mc.duke.edu
Successful reperfusion after acute myocardial infarction (MI) has traditionally been considered to be restoration of epicardial patency, but increasing evidence suggests that disordered microvascular function and inadequate myocardial tissue perfusion are often present despite infarct vessel patency. Thus, optimal reperfusion is being redefined to include intact microvascular flow and restored myocardial perfusion, as well as sustained epicardial patency. Coronary angiography has been used as the gold standard to define failed reperfusion, according to the Thrombolysis In Myocardial Infarction (TIMI) flow grades. However, new angiographic techniques, including the corrected TIMI frame count and myocardial blush grade, have been used to show that epicardial TIMI flow grade 3 may be an incomplete measure of reperfusion success. Furthermore, evolving noninvasive diagnostic techniques, including measurement of infarct size with cardiac marker release patterns or technetium-99msestamibi single-photon emission computed tomographic imaging and analysis of ST segment resolution appear to be useful complements to angiography for the assessment of myocardial tissue reperfusion. Promising adjunctive therapies that target microvascular dysfunction, including platelet glycoprotein IIb/IIIa inhibitors, and agents designed to improve tissue perfusion and attenuate reperfusion injury are being evaluated to further improve clinical outcomes after acute MI. To accelerate development of these new reperfusion regimens, an integrated approach to phase II clinical trials that incorporates multiple efficacy variables, including angiography and noninvasive biomarkers of microvascular dysfunction, should be considered. Thus, as the reperfusion era moves into the next millennium, the open-artery hypothesis is expected to shift downstream and guide efforts to further improve myocardial salvage and clinical outcomes after acute MI.
| ||||||||||||||||||||||
This article has been cited by other articles:
![]() |
M. Majidi, A. S. Kosinski, S. M. Al-Khatib, M. E. Lemmert, L. Smolders, A. van Weert, J. H.C. Reiber, D. Tzivoni, F. W.H.M. Bar, H. J.J. Wellens, et al. Reperfusion ventricular arrhythmia 'bursts' in TIMI 3 flow restoration with primary angioplasty for anterior ST-elevation myocardial infarction: a more precise definition of reperfusion arrhythmias Europace, August 1, 2008; 10(8): 988 - 997. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Valgimigli, G. Campo, G. Percoco, L. Bolognese, C. Vassanelli, S. Colangelo, N. de Cesare, A. E. Rodriguez, M. Ferrario, R. Moreno, et al. Comparison of Angioplasty With Infusion of Tirofiban or Abciximab and With Implantation of Sirolimus-Eluting or Uncoated Stents for Acute Myocardial Infarction: The MULTISTRATEGY Randomized Trial JAMA, April 16, 2008; 299(15): 1788 - 1799. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. McDonald, Y. Fu, U. Zeymer, G. Wagner, S. G. Goodman, A. Ross, C. B. Granger, F. Van de Werf, P. W. Armstrong, and for the ASSENT-4 PCI Investigators Adverse outcomes in fibrinolytic-based facilitated percutaneous coronary intervention: insights from the ASSENT-4 PCI electrocardiographic substudy Eur. Heart J., April 1, 2008; 29(7): 871 - 879. [Abstract] [Full Text] [PDF] |
||||
![]() |
Direct Inhibition of {delta}-Protein Kinase C Enzy Intracoronary KAI-9803 as an Adjunct to Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction Circulation, February 19, 2008; 117(7): 886 - 896. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Maioli, F. Bellandi, M. Leoncini, A. Toso, and R. P. Dabizzi Randomized Early Versus Late Abciximab in Acute Myocardial Infarction Treated With Primary Coronary Intervention (RELAx-AMI Trial) J. Am. Coll. Cardiol., April 10, 2007; 49(14): 1517 - 1524. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lerman, D. R. Holmes, J. Herrmann, and B. J. Gersh Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both? Eur. Heart J., April 1, 2007; 28(7): 788 - 797. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Montisci, L Chen, M Ruscazio, P Colonna, C Cadeddu, C Caiati, M Montisci, L Meloni, and S Iliceto Non-invasive coronary flow reserve is correlated with microvascular integrity and myocardial viability after primary angioplasty in acute myocardial infarction Heart, August 1, 2006; 92(8): 1113 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Suzuki, T. Sakaue, M. Tanaka, E. Hirose, H. Saeki, T. Matsunaka, S. Hiramatsu, and Y. Kazatani Association Between Right Bundle Branch Block and Impaired Myocardial Tissue-Level Reperfusion in Patients With Acute Myocardial Infarction J. Am. Coll. Cardiol., May 16, 2006; 47(10): 2122 - 2124. [Full Text] [PDF] |
||||
![]() |
R. H. Christenson, C. P. deFilippi, and D. Kreutzer Biomarkers of Ischemia in Patients With Known Coronary Artery Disease: Do Interleukin-6 and Tissue Factor Measurements During Dobutamine Stress Echocardiography Give Additional Insight? Circulation, November 22, 2005; 112(21): 3215 - 3217. [Full Text] [PDF] |
||||
![]() |
U. Zeymer, R. Zahn, R. Schiele, W. Jansen, E. Girth, A. Gitt, K. Seidl, R. Schroder, S. Schneider, and J. Senges Early eptifibatide improves TIMI 3 patency before primary percutaneous coronary intervention for acute ST elevation myocardial infarction: results of the randomized integrilin in acute myocardial infarction (INTAMI) pilot trial Eur. Heart J., October 1, 2005; 26(19): 1971 - 1977. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Huber, R. D. Caterina, S. D. Kristensen, F. W.A. Verheugt, G. Montalescot, L. B. Maestro, F. V. d. Werf, and for the Task Force on Pre-hospital Reperfusion The Pre-hospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction Eur. Heart J., October 1, 2005; 26(19): 2063 - 2074. [Full Text] [PDF] |
||||
![]() |
S R Dixon Infarct angioplasty: beyond stents and glycoprotein IIb/IIIa inhibitors Heart, June 1, 2005; 91(suppl_3): iii2 - iii6. [Full Text] [PDF] |
||||
![]() |
A. Schomig and A. Kastrati Distal Embolic Protection in Patients With Acute Myocardial Infarction: Attractive Concept But No Evidence of Benefit JAMA, March 2, 2005; 293(9): 1116 - 1118. [Full Text] [PDF] |
||||
![]() |
B. J. Gersh, G. W. Stone, H. D. White, and D. R. Holmes Jr Pharmacological Facilitation of Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: Is the Slope of the Curve the Shape of the Future? JAMA, February 23, 2005; 293(8): 979 - 986. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Krucoff, P. Johanson, R. Baeza, S. W. Crater, and M. Dellborg Clinical Utility of Serial and Continuous ST-Segment Recovery Assessment in Patients With Acute ST-Elevation Myocardial Infarction: Assessing the Dynamics of Epicardial and Myocardial Reperfusion Circulation, December 21, 2004; 110(25): e533 - e539. [Full Text] [PDF] |
||||
![]() |
A. Kastrati, J. Mehilli, S. Nekolla, H. Bollwein, S. Martinoff, J. Pache, H. Schuhlen, M. Seyfarth, M. Gawaz, F.-J. Neumann, et al. A randomized trial comparing myocardial salvage achieved by coronary stenting versus balloon angioplasty in patients with acute myocardial infarction considered ineligible for reperfusion therapy J. Am. Coll. Cardiol., March 3, 2004; 43(5): 734 - 741. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Roe, C. L. Green, R. P. Giugliano, C. M. Gibson, K. Baran, M. Greenberg, S. T. Palmeri, S. Crater, K. Trollinger, K. Hannan, et al. Improved speed and stability of st-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute st-segment elevation myocardial infarction J. Am. Coll. Cardiol., February 18, 2004; 43(4): 549 - 556. [Abstract] [Full Text] [PDF] |
||||
![]() |
J A de Lemos and J J Warner New tools for assessing microvascular obstruction in patients with ST elevation myocardial infarction Heart, February 1, 2004; 90(2): 119 - 120. [Full Text] [PDF] |
||||
![]() |
M Sezer, Y Nisanci, B Umman, E Yilmaz, A Olcay, F Erzengin, and O Ozsaruhan New support for clarifying the relation between ST segment resolution and microvascular function: degree of ST segment resolution correlates with the pressure derived collateral flow index Heart, February 1, 2004; 90(2): 146 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kunichika, O. Ben-Yehuda, S. Lafitte, N. Kunichika, B. Peters, and A. N. DeMaria Effects of glycoprotein iib/iiia inhibition on microvascular flow after coronary reperfusion: A quantitative myocardial contrast echocardiography study J. Am. Coll. Cardiol., January 21, 2004; 43(2): 276 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Hoffmann, P Haager, W Lepper, A Franke, and P Hanrath Relation of coronary flow pattern to myocardial blush grade in patients with first acute myocardial infarction Heart, October 1, 2003; 89(10): 1147 - 1151. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Giugliano, M. T. Roe, R. A. Harrington, C. M. Gibson, U. Zeymer, F. Van de Werf, K. W. Baran, H.-P. Hobbach, L. H. Woodlief, K. L. Hannan, et al. Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: Results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic urial J. Am. Coll. Cardiol., April 16, 2003; 41(8): 1251 - 1260. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dibra, J. Mehilli, J. Dirschinger, J.u. Pache, J. Neverve, M. Schwaiger, A. Schomig, and A. Kastrati Thrombolysis in myocardial infarction myocardial perfusion grade in angiography correlates with myocardial salvage in patients with acute myocardial infarction treated with stenting or thrombolysis J. Am. Coll. Cardiol., March 19, 2003; 41(6): 925 - 929. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Haager, P. Christott, N. Heussen, W. Lepper, P. Hanrath, and R. Hoffmann Prediction of clinical outcome after mechanical revascularization in acute myocardial infarction by markers of myocardial reperfusion J. Am. Coll. Cardiol., February 19, 2003; 41(4): 532 - 538. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.S Petronio, D Rovai, G Musumeci, R Baglini, C Nardi, U Limbruno, C Palagi, D Volterrani, and M Mariani Effects of abciximab on microvascular integrity and left ventricular functional recovery in patients with acute infarction treated by primary coronary angioplasty Eur. Heart J., January 1, 2003; 24(1): 67 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Voci, E. Mariano, F. Pizzuto, P. E. Puddu, and F. Romeo Coronary recanalization in anterior myocardial infarction: The open perforator hypothesis J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1205 - 1213. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sagar and J. Jurva Open perforator hypothesis: Bridging epicardial and microvascular circulation J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1214 - 1215. [Full Text] [PDF] |
||||
![]() |
C.-K. Wong, J.K. French, M.W. Krucoff, W. Gao, P.E. Aylward, and H.D. White Slowed ST segment recovery despite early infarct artery patency in patients with Q waves at presentation with a first acute myocardial infarction. Implications of initial Q waves on myocyte reperfusion Eur. Heart J., September 2, 2002; 23(18): 1449 - 1455. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Agati, S. Funaro, M. Madonna, C. Volponi, G. Veneroso, and G. Tonti Clinical utility of contrast echocardiography in the management of patients with acute myocardial infarction Eur. Heart J. Suppl., March 1, 2002; 4(suppl_C): C27 - C34. [Abstract] [PDF] |
||||
![]() |
S. H. Rezkalla and R. A. Kloner No-Reflow Phenomenon Circulation, February 5, 2002; 105(5): 656 - 662. [Full Text] [PDF] |
||||
![]() |
B. G. Angeja, M. Gunda, S. A. Murphy, B. E. Sobel, A. C. Rundle, M. Syed, A. Asfour, S. Borzak, S. G. Gourlay, H. V. Barron, et al. TIMI Myocardial Perfusion Grade and ST Segment Resolution: Association With Infarct Size as Assessed by Single Photon Emission Computed Tomography Imaging Circulation, January 22, 2002; 105(3): 282 - 285. [Abstract] [Full Text] [PDF] |
||||
![]() |
A H Gershlick The acute management of myocardial infarction Br. Med. Bull., October 1, 2001; 59(1): 89 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. O'Shea, G. E. Hafley, S. Greenberg, V. Hasselblad, T. J. Lorenz, M. M. Kitt, J. Strony, J. E. Tcheng, and for the ESPRIT Investigators Platelet Glycoprotein IIb/IIIa Integrin Blockade With Eptifibatide in Coronary Stent Intervention: The ESPRIT Trial: A Randomized Controlled Trial JAMA, May 16, 2001; 285(19): 2468 - 2473. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Ohman, R. A. Harrington, C. P. Cannon, G. Agnelli, J. A. Cairns, and J.W. Kennedy Intravenous Thrombolysis in Acute Myocardial Infarction Chest, January 1, 2001; 119(1_suppl): 253S - 277S. [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |